Inhibitor Therapeutics, Inc. Net Income (Loss) Attributable to Parent, Diluted
Inhibitor Therapeutics, Inc. (INTI) reported Net Income (Loss) Attributable to Parent, Diluted of -$1.84 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-04-15.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToParentDiluted · last filed 2014-04-15
- Inhibitor Therapeutics, Inc. net income (loss) attributable to parent, diluted for fiscal 2013 was -$1.84M, a 1084.65% decline from fiscal 2012.
- Inhibitor Therapeutics, Inc. net income (loss) attributable to parent, diluted for fiscal 2012 was $186.37K.
| Period end | Net Income (Loss) Attributable to Parent, Diluted 12 month |
|---|---|
| 2013-12-31 | -$1.84M 10-K · filed 2014-04-15 |
| 2012-12-31 | $186.37K 10-K · filed 2014-04-15 |